Large-scale testing (Phase 3)Not Yet RecruitingNCT06925971
What this trial is testing
Trial of the Rapamycin Target Eluting Stent for the Treatment of Symptomatic Cerebral Artery Atherosclerotic Disease(TARGET-DREAM)
Who this might be right for
Intracranial Arteriosclerosis
MicroPort NeuroTech Co., Ltd. 279